Org 24598 lithium saltSelective GlyT1 inhibitor CAS# 722456-08-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 722456-08-8 | SDF | Download SDF |
PubChem ID | 16219807 | Appearance | Powder |
Formula | C19H19F3LiNO3 | M.Wt | 373.3 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 10 mM in water and to 5 mM in DMSO | ||
Chemical Name | lithium;2-[methyl-[(3R)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]amino]acetate | ||
SMILES | [Li+].CN(CCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F)CC(=O)[O-] | ||
Standard InChIKey | VMQXVSNARQMSDL-UNTBIKODSA-M | ||
Standard InChI | InChI=1S/C19H20F3NO3.Li/c1-23(13-18(24)25)12-11-17(14-5-3-2-4-6-14)26-16-9-7-15(8-10-16)19(20,21)22;/h2-10,17H,11-13H2,1H3,(H,24,25);/q;+1/p-1/t17-;/m1./s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Selective inhibitor of the glial glycine transporter (GlyT1) (pIC50 values are 6.9, <4 and <3 for GlyT1, GABA transporter and Glyt2 respectively). |
Org 24598 lithium salt Dilution Calculator
Org 24598 lithium salt Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6788 mL | 13.3941 mL | 26.7881 mL | 53.5762 mL | 66.9703 mL |
5 mM | 0.5358 mL | 2.6788 mL | 5.3576 mL | 10.7152 mL | 13.3941 mL |
10 mM | 0.2679 mL | 1.3394 mL | 2.6788 mL | 5.3576 mL | 6.697 mL |
50 mM | 0.0536 mL | 0.2679 mL | 0.5358 mL | 1.0715 mL | 1.3394 mL |
100 mM | 0.0268 mL | 0.1339 mL | 0.2679 mL | 0.5358 mL | 0.6697 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Laurifoline
Catalog No.:BCN4278
CAS No.:7224-61-5
- 2alpha-Hydroxyeupatolide 8-O-angelate
Catalog No.:BCN7340
CAS No.:72229-39-1
- 2-Hydroxyeupatolide
Catalog No.:BCN2490
CAS No.:72229-33-5
- Echitovenidine
Catalog No.:BCN7482
CAS No.:7222-35-7
- Parsonsine
Catalog No.:BCN2111
CAS No.:72213-98-0
- Calcitetrol
Catalog No.:BCC1446
CAS No.:72203-93-1
- Aflatoxin B2
Catalog No.:BCC9213
CAS No.:7220-81-7
- 2-Hydroxyplatyphyllide
Catalog No.:BCN7119
CAS No.:72145-19-8
- b-Casomorphin (1-3)
Catalog No.:BCC1007
CAS No.:72122-59-9
- Nerolidol
Catalog No.:BCN5459
CAS No.:7212-44-4
- Prilocaine
Catalog No.:BCC4929
CAS No.:721-50-6
- Mastoparan X
Catalog No.:BCC5833
CAS No.:72093-22-2
- AZD1152
Catalog No.:BCC1393
CAS No.:722543-31-9
- Barasertib (AZD1152-HQPA)
Catalog No.:BCC2168
CAS No.:722544-51-6
- Malvidin-3-O-glucoside chloride
Catalog No.:BCN3031
CAS No.:7228-78-6
- Streptolydigin
Catalog No.:BCN1858
CAS No.:7229-50-7
- Sulfamethoxazole
Catalog No.:BCC4857
CAS No.:723-46-6
- 9-AC
Catalog No.:BCC6867
CAS No.:723-62-6
- Rivularine
Catalog No.:BCN2038
CAS No.:723-78-4
- ZLN024
Catalog No.:BCC5527
CAS No.:723249-01-2
- ZJ 43
Catalog No.:BCC2355
CAS No.:723331-20-2
- Beta-Carotene
Catalog No.:BCN4965
CAS No.:7235-40-7
- Licoflavone C
Catalog No.:BCN3256
CAS No.:72357-31-4
- Isobellendine
Catalog No.:BCN1916
CAS No.:72362-45-9
The time course of transmitter at glycinergic synapses onto motoneurons.[Pubmed:18632945]
J Neurosci. 2008 Jul 16;28(29):7412-25.
The concentration of transmitter in the synaptic cleft and its clearance time are one of the main determinants of synaptic strength. We estimated the time course of glycine at rat lumbar motoneurons synapses in spinal cord slices by recording synaptic currents in the presence of a low-affinity competitive antagonist at glycine receptors [2-(3-carboxypropyl)-3-amino-6-(4-methoxyphenyl)pyridazinium (SR-95531)]. Data were analyzed by using the established activation mechanism for glycine receptors and our measurements of SR-95531 binding rates. We show that this technique alone is not sufficient to determine simultaneously the peak concentration of transmitter and its clearance time. However, we found that block of the glial glycine transporter prolongs the glycine transient. This observation puts additional constraints on the range of possible values of the time course of glycine, indicating that glycine reaches a peak concentration of 2.2-3.5 mM and is cleared from the cleft with a time constant of 0.6-0.9 ms.
Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord.[Pubmed:15235081]
J Physiol. 2004 Aug 15;559(Pt 1):169-86.
Using whole cell voltage clamp recordings from lamina X neurones in rat spinal cord slices, we investigated the effect of glycine transporter (GlyT) antagonists on both glycinergic inhibitory postsynaptic current (IPSCs) and glutamatergic excitatory postsynaptic current (EPSCs). We used ORG 24598 and ORG 25543, selective antagonists of the glial GlyT (GlyT1) and neuronal GlyT (GlyT2), respectively. In rats (P12-P16) and in the presence of kynurenic acid, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and bicuculline, ORG 24598 and ORG 25543 applied individually at a concentration of 10 microm induced a mean inward current of -10/-50 pA at -60 mV and increased significantly the decay time constants of miniature (mIPSCs), spontaneous (sIPSCs) and electrically evoked glycinergic (eIPSCs) inhibitory postsynaptic currents. ORG 25543, but not ORG 24598, decreased the frequency of mIPSCs and sIPSCs. Replacing extracellular sodium with N-methyl-d-glucamine or superfusing the slice with micromolar concentrations of glycine also increased the decay time constant of glycinergic IPSCs. By contrast, the decay time constant, amplitude and frequency of miniature GABAergic IPSCs recorded in the presence of strychnine were not affected by ORG 24598 and ORG 25543. In the presence of strychnine, bicuculline and CNQX, we recorded electrically evoked NMDA receptor-mediated EPSCs (eEPSCs). eEPSCs were suppressed by 30 micromd-2-amino-5-phosphonovalerate (APV), an antagonist of the NMDA receptor, and by 30 microm dichlorokynurenic acid (DCKA), an antagonist of the glycine site of the NMDA receptor. Glycine (1-5 microm) and d-serine (10 microm) increased the amplitude of eEPSCs whereas l-serine had no effect. ORG 24598 and ORG 25543 increased significantly the amplitude of NMDA receptor-mediated eEPSCs without affecting the amplitude of non-NMDA receptor-mediated eEPSCs. We conclude that blocking glial and/or neuronal glycine transporters increased the level of glycine in spinal cord slices, which in turn prolonged the duration of glycinergic synaptic current and potentiated the NMDA-mediated synaptic response.